Hosted on MSN11mon
COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q4 2023
Cocrystal Pharma (NASDAQ:COCP) just reported results for the fourth quarter of 2023. Cocrystal Pharma reported earnings per share of -44 cents. This was above the analyst estimate for EPS of -60 ...
Hosted on MSN2mon
Cocrystal stock plunges 40% on influenza drug update
Shares of Cocrystal Pharma (NASDAQ:COCP) plunged 40% Tuesday after the company said it plans to extend a Phase 2a challenge study for its influenza drug candidate CC-42344 due to an unexpectedly ...
ETF Daily News13d
Cocrystal Pharma, Inc. (NASDAQ:COCP) Sees Significant Decrease in Short Interest
Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) was the recipient of a significant decline in short interest in February.As of February 15th, there was short interest totalling 14,400 ...